And fourth, focus on changing the environment, not just people. We must shift the focus to the systems and structures that ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein ...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with ...

Presentations highlight clinically meaningful reductions in BMI in patients with acquired hypothalamic obesity - ...

SINGAPORE - An injectable drug used to treat obesity is now available via prescription from any licensed physician in ...

By the time your eyes finish scanning this line, someone in Punjab just checked their sugar levels after skipping breakfast - ...

An oral melanocortin-4 receptor agonist conferred significant BMI reductions among adolescents and adults with hypothalamic obesity, according to a presenter. As Healio previously reported, ...

Over 60 novel drug candidates are in late-stage clinical trials in China, and these will potentially compete directly with US ...

This increase in risk is associated with relatively small amounts of processed meat, equivalent to just two rashers of bacon, ...

ENDO 2025 spotlights breakthrough research in PCOS, obesity, diabetes, and rare endocrine disorders and offers practical updates for daily clinical care. As the sun rises over San Francisco, ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced obesity-associated breast ...

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...